The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: oxaliplatin     Quarter: 2016Q3

Total Records: 864     Number of Pages: 44

DRUGNAME PT EventCount
OXALIPLATIN 5mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION Acute respiratory failure 2
OXALIPLATIN 5mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION Dysphonia 2
OXALIPLATIN 5mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION Muscle spasms 2
Oxaliplatin Aurobindo 5 mg/ml concentrate for solution Anaphylactic reaction 2
Oxaliplatin Aurobindo 5 mg/ml concentrate for solution Rash 2
Oxaliplatin Hospira Chills 2
OXALIPLATIN HOSPIRA Dysphemia 2
Oxaliplatin Hospira Hyperhidrosis 2
Oxaliplatin Hospira Hypersensitivity 2
OXALIPLATIN HOSPIRA Joint stiffness 2
Oxaliplatin Hospira Oxygen saturation decreased 2
OXALIPLATIN HOSPIRA Stridor 2
OXALIPLATIN HOSPIRA Transient ischaemic attack 2
OXALIPLATIN INJECTION 50MG/10 ML and 100MG/20ML Anaphylactic reaction 2
OXALIPLATIN. Abdominal discomfort 2
OXALIPLATIN. Abdominal sepsis 2
OXALIPLATIN. Acute respiratory failure 2
OXALIPLATIN. Adenocarcinoma of colon 2
OXALIPLATIN. Adverse drug reaction 2
OXALIPLATIN. Alopecia totalis 2

Total Records: 864     Number of Pages: 44